Animal models of ventilator-associated pneumonia

European Respiratory Journal

Volumn 33, Issue 1, 2009, Pages 182-188

  Luna, C M ^a,d   Sibila, O ^b   Agusti, C ^c   Torres, A ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d NONE   (Argentina)

Author keywords

Animal model; Antimicrobial therapy; Inflammatory markers; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; FENTANYL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MIDAZOLAM; PANCURONIUM BROMIDE; POLYMYXIN; PROTEIN P55; PROTEIN P75; QUINOLONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANALGESIA; ANALYTICAL PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; BABOON; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIOLOGY; BACTERIUM CULTURE; BODY POSTURE; BRONCHUS; CELL MIGRATION; CLINICAL PRACTICE; CLINICAL STUDY; DISEASE CLASSIFICATION; DRUG ABSORPTION; DRUG TISSUE LEVEL; ERADICATION THERAPY; ESCHERICHIA COLI; EXPERIMENTAL CAT; EXPERIMENTAL DOG; EXPERIMENTAL MODEL; EXPERIMENTAL PIG; GROUP B STREPTOCOCCAL INFECTION; HOSPITAL INFECTION; IN VITRO STUDY; INFLAMMATION; INOCULATION; INTUBATION; KLEBSIELLA OXYTOCA; LUNG ASPIRATION; LUNG HOMOGENATE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL PARAMETERS; NEPHROTOXICITY; NONHUMAN; PARALYSIS; PASTEURELLA MULTOCIDA; PATHOPHYSIOLOGY; PHYSIOLOGY; PIGLET; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; REVIEW; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA;

ANIMALS; ANTI-INFECTIVE AGENTS; CATS; DISEASE MODELS, ANIMAL; DOGS; PNEUMONIA, VENTILATOR-ASSOCIATED; SWINE;

EID: 58849146133     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00046308     Document Type: Review

References (40)

1. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133: 792-796.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
3. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 1998; 158: 1839-1847.
4. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Brandt B, Doyle B, Weintraub H, Harrison H. Pulmonary artery pressure and lung water during extracorporeal circulation in experimental pulmonary insufficiency. Ann Thorac Surg 1975; 20: 308-315.
6. Tilson MD, Bunke MC, Smith GJ, et al. Quantitative bacteriology and pathology of the lung in experimental Pseudomonas pneumonia treated with positive endexpiratory pressure (PEEP). Surgery 1977; 82: 133-140.
7. Moser KM, Maurer J, Jassy L, et al. Sensitivity, specificity, and risk of diagnostic procedures in a canine model of Streptococcus pneumoniae pneumonia. Am Rev Respir Dis 1982; 125: 436-442.
8. Campbell GD, Coalson JJ, Johanson WG Jr. The effect of bacterial superinfection on lung function after diffuse alveolar damage. Am Rev Respir Dis 1984; 129: 974-978.
9. Johanson WG Jr, Seidenfeld JJ, Gomez P, de los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137: 259-264.
10. Johanson WG Jr, Seidenfeld JJ, de los Santos R, Coalson JJ, Gomez P. Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Am Rev Respir Dis 1988; 137: 265-272.
11. Marquette CH, Mensier E, Copin MC, et al. Experimental models of tracheobronchial stenoses: a useful tool for evaluating airway stents. Ann Thorac Surg 1995; 60: 651-656.
12. Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999; 115: 200-209.
13. Rouby JJ, Martin De Lassale E, Poete P, et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146: 1059-1066.
14. Luna CM, Baquero S, Gando S, et al. Experimental severe Pseudomonas aeruginosa pneumonia and antibiotic therapy in piglets receiving mechanical ventilation. Chest 2007; 132: 523-531.
15. Wermert D, Marquette CH, Copin MC, et al. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998; 158: 139-147.
16. Bruno D, Luna CM, Garcia Morato J, et al. Linezolid (LZD) versus vancomycin (VAN) and teicoplanin (TEI) for severe methicillin-resistant Staphylococcus aureus (MRSA) pneumonia in an animal model. Program and abstracts of ATS 2008. International Conference of the American Thoracic Society. Am J Respir Crit Care Med 2008; 177: A287.
17. Elman M, Goldstein I, Marquette CH, et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002; 97: 199-206.
18. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002; 166: 1375-1381.
19. Goldstein I, Bughalo MT, Marquette CH, et al. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001; 163: 958-964.
20. Rios Vieira SR, Goldstein I, Lenaour G, et al. Experimental ventilator-associated pneumonia: distribution of lung infection and consequences for lung aeration. Braz J Infect Dis 2003; 7: 216-223.
21. van Kaam AHLC, Lutter R, Lacmann RA, et al. Effect of ventilation strategy and surfactant on inflammation in experimental pneumonia. Eur Respir J 2005; 26: 112-117.
22. Marquette CH, Copin MC, Wallet F, et al. Relationship between microbiologic and histologic features in bacterial pneumonia. Am J Respir Crit Care Med 1996; 154: 1784-1787.
23. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141: 471-501.
24. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumour necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159: 189-194.
25. Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999;27:1745-1753.
26. Schütte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996; 9: 1858-1867.
27. Fernández-Serrano S, Dorca J, Coromines M, Carratalà J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community acquired pneumonia. Clin Diagn Lab Immunol 2003;10:813-820.
28. Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med 2004; 32: 938-945.
29. Sibila O, Agustí C, Torres A, et al. Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response. Eur Respir J 2007; 30: 1167-1172.
30. Sibila O, Martinez-Olondris P, Agustí C, et al. An experimental model of pneumonia induced by MRSA in ventilated piglets. Program and abstracts of ATS 2008. International Conference of the American Thoracic Society. Am J Respir Crit Care Med 2007; 175: A327.
31. Sibila O, Luna CM, Agustí C, et al. Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J 2008; 32: 1037-1046.
32. Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother 1990; 34: 614-621.
33. Moore RD, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 1984; 77: 657-662.
34. Schentag JJ. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Scand J Infect Dis Suppl 1990; 74: 218-234.
35. Dull WL, Alexander MR, Kasik JE. Bronchial secretion levels of amikacin. Antimicrob Agents Chemother 1979; 16: 767-771.
36. Even P, Bergogne-Berezin E, Reynaud P, Berthelot G. [Pharmacokinetics of amikacin in bronchial secretions]. Nouv Presse Med 1979; 8: 3441-3444.
37. Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 1985; 132: 761-765.
38. Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981; 3: 67-73.
39. Saux MC, Crockett R, Fourtillan JB, Leng B, Couraud L. Diffusion of amikacin in the lungs. Pathol Biol (Paris) 1986; 34: 113-117.
40. Tonnellier M, Ferrari F, Goldstein I, Sartorius A, Marquette CH, Rouby JJ. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 2005; 102: 995-1000.